🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Is #COVID19 ARDS different from all-cause #ARDS?? Significantly! in radiological & physiological features (relationship oxygenation/lung mechanics & responses to PEEP). Peculiarities of different stages of disease require rethinking protective MV targets bit.ly/2Thbf9w

thelancet.com/journals/lanre… role of perfusion imaging after COVID-19

ahajournals.org/doi/abs/10.116…

Unequivocal evidence that pulmonary functional impairment even in moderate COVID-19 is predominantly vascular. Alveolar function is normal. Gas exchange against the pulmonary capillary bed is impaired. It is a dead space issue even before thrombosis begins.

More evidence consistent with the view that extrapulmonary organ damage in moderate to severe COVID-19 is largely vascular/thrombotic rather than viral/cytopathic. onlinelibrary.wiley.com/doi/10.1111/ij… From Dr. Brandon (🔒) and colleagues.

Nice graphic from x.com/drrobinCCM/sta… Breathlessness occurs late, and is not reliable indicator of deterioration until severe illness. Makes symptom-based assessment unreliable. Identifying Desaturation on exertion early permits intervention & may avoid ITU & ARDS

Have reviewed a lot of papers on clots in severe COVID-19 in last weeks & most ignored immunothrombosis as cause of segmental/subsegmental changes on CTPA & counted them as “PE” It’s time to for all to acknowledge this phenomenon & move on!

Segun Olusanya (He/Him) [email protected] Really think it’s that confusing?? The so called “pneumonia” is an immunothrombotic endothelial activated process. That is the injury. Once severe, much injury has occurred, now dealing with much of the downstream effects. Robin Cherian @farid__jalali

Antiphospholipid syndrome and COVID-19 thrombosis: connecting the dots. Sharing our review article published in Rheumatology & Rheumatology Advances in Practice doi.org/10.1093/rap/rk… BSR Jason S Knight @YogenKanthi

🕸️👀 Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19 nature.com/articles/s4157…

Therapeutic anticoagulation increases survival to hospital discharge in non-critically ill COVID.

Our study explaining the pathophysiology of acute COVID has been published by ERJ, the flagship scientific journal of the European Respiratory Society ERS publications. Here, we describe how severe COVID-19 is NOT a viral pneumonia, but a post-viral autoimmune attack of the lung.

Pleased to share our letter in The Lancet Respiratory Medicine. We propose that pulmonary infarction (in COVID-19 and other pulmonary vaso-occlusive disorders) occurs primarily due to congestion and oxidative stress rather than due to hypoxia. thelancet.com/journals/lanre… @NUHS

Pleased to share our letter The Lancet Rheumatology arguing that severe COVID-19 is a virus-independent immunothrombotic process. thelancet.com/journals/lanrh… describe

A day in the life of ⁦⁦Ting Ting LOW⁩ who makes multitasking look so easy 💪🏻 Thanks for flying the #NUHCS flag high-we are lucky to have you as a great doctor, amazing colleague & honest friend! #wic #womeninmedicine #internationalwomensday #iwd2022 fb.watch/bxAOlr08i0/?mi…

Rachna Kataria, MD Nikhil Narang, MD Anju Bhardwaj MD FACC Jenny Thibodeau, MD, MSCS JACC Journals @ersied727 Kevin S Shah, MD Viviana Navas, MD @bhtrachtenberg Eiran Gorodeski, MD, MPH Justin Vader Andrew J Sauer MD @IRajapreyar Ryan J Tedford MD Jonathan Davis, MD, MPHS @JJheart_doc Gregory Macaluso Ashwin R Shelley Zieroth Harriette Van Spall, MD MPH 🇨🇦 Sumeet Singh Mitter, MD, MSc Mark Dela Cruz Nosheen Reza, MD, MS Luise Holzhauser, MD And this one: Trejeeve (Tre) Martyn Randall Starling Journal of Cardiac Failure onlinejcf.com/article/S1071-…

short how to do video on how to do #echofirst 3D with TEE looking at tricuspid valve francesca graziani_FG Benoy Shah MD Enjoy. C you soon in Berlin

To PAC or not to PAC❓ 🔥 PAC ass/w ⬇️ in-hospital mortality in HF-CS, esp if within 6hrs of admission ‼️ Manreet Kanwar Navin Kapur Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA Dan Burkhoff MD PhD A. Reshad Garan MD Jacob Abraham, MD Robert Mentz, MD Anu Lala-Trindade onlinejcf.com/article/S1071-… cardiogenicshocksummit.org for more ❤️‍🔥

Presented today at #ACC24: In the DanGer Shock trial involving patients with STEMI and cardiogenic shock, mortality at 6 months was lower with mechanical circulatory support with a microaxial flow pump than with standard care alone. Full trial results: nej.md/3xyXU3t